Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
GPRC5B preserves a mature β cell state in obesity by controlling MafA expression
Tianpeng Wang, … , Stefan Günther, Nina Wettschureck
Tianpeng Wang, … , Stefan Günther, Nina Wettschureck
Published September 4, 2025
Citation Information: JCI Insight. 2025;10(20):e194115. https://doi.org/10.1172/jci.insight.194115.
View: Text | PDF
Research Article Endocrinology Metabolism

GPRC5B preserves a mature β cell state in obesity by controlling MafA expression

  • Text
  • PDF
Abstract

In vitro studies have implicated orphan receptor GPRC5B in β cell survival, proliferation, and insulin secretion, but its relevance for glucose homeostasis in vivo is largely unknown. Using tamoxifen-inducible, β cell–specific GPRC5B-KO mice (Ins-G5b–KOs), we show here that loss of GPRC5B does not affect β cell function in the lean state but results in strongly reduced insulin secretion and disturbed glucose tolerance in mice subjected to high-fat diet for 16 weeks. Flow cytometry and single-cell expression analyses in islets from obese mice show a reduced β cell abundance and a less mature β cell phenotype in Ins-G5b–KOs. Expression of β cell–specific transcription factor MafA is reduced both on the RNA and protein level, as are transcripts of MafA target genes. Mechanistically, we show that phosphorylation of cAMP response element-binding protein (CREB), a major regulator of MafA expression, is reduced in islets of obese Ins-G5b–KOs, and we show that this phenotype precedes the downregulation of MafA and MafA target genes. Taken together, GPRC5B helps to maintain mature β cell function in obesity through cAMP/CREB-dependent regulation of MafA expression.

Authors

Tianpeng Wang, Remy Bonnavion, Janett Piesker, Stefan Günther, Nina Wettschureck

×

Figure 4

Single-cell transcriptome characterization of pancreatic islets from obese Ins-G5b–KOs.

Options: View larger image (or click on image) Download as PowerPoint
Single-cell transcriptome characterization of pancreatic islets from obe...
(A) t-SNE plot showing clustering of islet cells harvested from 3 control mice (WT1–WT3, n = 12,928 cells) and 2 Ins-G5b–KO mice (KO1 and KO2, n = 9,889) fed for 16 weeks with HFD. (B and C) Contribution of control (WT) and KO cells to the different clusters: t-SNE plot (B) and relative cluster size in individual mice (C). (D) Volcano plot showing genes that there are differentially expressed in β cells from obese Ins-G5b–KOs versus obese control mice. Genes with a well-established role in β cell biology are shown in red. (E and F) Dot plots showing expression frequency (%) and strength of top 10 downregulated genes in β cell clusters 1 and 8 from control (WT) and Ins-G5b–KOs (KO). (G) Dot plots showing expression levels of other MafA target genes within the β cell clusters. Data are mean ± SEM; comparisons between control and KO samples were performed using 2-way repeated measures ANOVA with Šidák’s multiple-comparison test (C). EC, endothelial cells; Leuko, leukocytes; na-1/na-2, not yet annotated clusters 1 and 2. *P ≤ 0.05, **P ≤ 0.01, ****P ≤ 0.0001.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts